XML 91 R75.htm IDEA: XBRL DOCUMENT
v3.6.0.2

Significant Agreements (Details) $ in Millions |  | 1 Months Ended | 12 Months Ended
--- | --- | --- | ---
Oct. 29, 2014 compound | Nov. 30, 2014 USD ($) | Aug. 31, 2013 USD ($) | Dec. 31, 2014 USD ($)
Research and Development Arrangement, Contract to Perform for Others [Line Items] |  |  |  |
Deferred revenue recognition period (in months) |  |  | 70 months |
Number of compounds | compound | 2 |  |  |
Waterstone Licensing Agreement | Licensing Agreement |  |  |  |
Research and Development Arrangement, Contract to Perform for Others [Line Items] |  |  |  |
Milestone payment for first product registration |  | $ 4.0 |  |
Option exercise period | 18 months |  |  |
Contract term | 10 years |  |  |
Upfront payment |  | 1.0 |  |
Additional upfront payment |  | $ 0.5 |  |
Revenue from non-refundable upfront payment |  |  |  | $ 1.0
Development, License, and Supply Agreement | R-Pharm Collaboration Arrangement |  |  |  |
Research and Development Arrangement, Contract to Perform for Others [Line Items] |  |  |  |
Proceeds from collaborators |  |  | $ 1.5 |
Milestone payment for first product registration |  |  | 3.0 |
Sales based payments |  |  | $ 15.0 |
Deferred revenue recognition period (in months) |  |  | 70 months |

X
- Definition Additional Upfront Payment Under Licensing Arrangement + References No definition available. + Details
Name: | scyx_AdditionalUpfrontPaymentUnderLicensingArrangement
Namespace Prefix: | scyx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Collaborative Arrangement, Development Milestone Proceeds + References No definition available. + Details
Name: | scyx_CollaborativeArrangementDevelopmentMilestoneProceeds
Namespace Prefix: | scyx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Deferred revenue recognition period. + References No definition available. + Details
Name: | scyx_DeferredRevenueRecognitionPeriod
Namespace Prefix: | scyx_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of Compounds + References No definition available. + Details
Name: | scyx_NumberofCompounds
Namespace Prefix: | scyx_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Option Exercise Period For Additional Compounds Under License Agreement + References No definition available. + Details
Name: | scyx_OptionExercisePeriodForAdditionalCompoundsUnderLicenseAgreement
Namespace Prefix: | scyx_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Research and Development Arrangement, Commitment to Services Agreement, Term + References No definition available. + Details
Name: | scyx_ResearchandDevelopmentArrangementCommitmenttoServicesAgreementTerm
Namespace Prefix: | scyx_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Research and Development Arrangement, Contract to Perform for Others, Maximum Net Sales Target Proceeds + References No definition available. + Details
Name: | scyx_ResearchandDevelopmentArrangementContracttoPerformforOthersMaximumNetSalesTargetProceeds
Namespace Prefix: | scyx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Upfront Payment Under License Agreement + References No definition available. + Details
Name: | scyx_UpfrontPaymentUnderLicenseAgreement
Namespace Prefix: | scyx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(e)) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_LicensesRevenue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Cash received from collaborators during the current period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3536-108585 + Details
Name: | us-gaap_ProceedsFromCollaborators
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=scyx_WaterstoneLicensingAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=us-gaap_LicenseAgreementTermsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=scyx_RPharmCollaborationArrangementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |